Filter
2811
Filtered Results: 2811
Text search:
monitoring
of
adverse
effects
Featured
Recommendations
328
New Publications
758
Language
Document type
No document type
1558
Guidelines
489
Studies & Reports
419
Manuals
160
Strategic & Response Plan
98
Training Material
33
Fact sheets
32
Situation Updates
14
Resource Platforms
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
142
Global
113
Kenya
70
Western and Central Europe
62
South Africa
61
Ethiopia
61
Nepal
54
Nigeria
49
Africa
46
Uganda
45
Ghana
42
Tanzania
40
Latin America and the Carribbean
39
Sierra Leone
35
Zambia
35
Malawi
33
Myanmar / Burma
33
Bangladesh
30
Liberia
29
Philippines
25
Rwanda
23
Ukraine
21
Zimbabwe
20
South–East Asia Region
19
Syria
17
Eastern Europe
17
Namibia
17
East and Southern Africa
16
Cambodia
15
Indonesia
13
Guinea
12
Lesotho
11
West and Central Africa
11
Botswana
11
South Sudan
11
Senegal
10
Mozambique
10
USA
10
Asia
10
Germany
10
Middle East and North Africa
10
Eastern Europe and Central Asia
10
Eswatini/ Swaziland
10
Congo, Democratic Republic of
8
Western Pacific Region
8
Brazil
8
Sudan
8
Thailand
6
Moldova
6
Russia
6
Burkina Faso
5
Venezuela
5
Lebanon
5
Yemen
5
Pakistan
5
Laos
4
Afghanistan
4
Mali
4
Somalia
4
Tajikistan
3
Colombia
3
Timor Leste/ East Timor
3
Cameroon
3
Niger
3
Haiti
3
Jordan
3
Vietnam
3
Bhutan
3
Ecuador
3
Benin
2
Gambia
2
China
2
Singapore
2
Kyrgyzstan
2
North America
2
United Kingdom
2
Argentina
2
Sri Lanka
2
Egypt
2
Georgia
2
Central African Republic
2
Angola
2
Iraq
2
Madagascar
2
North Macedonia
1
North Korea
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Albania
1
Canada
1
Fiji
1
Burundi
1
Peru
1
Vanuatu
1
Mauritania
1
Lithuania
1
Ireland
1
Paraguay
1
Turkmenistan
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Djibouti
1
Romania
1
Greece
1
Palestine
1
Poland
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
947
Clinical Guidelines
322
Key Resources
178
Public Health
169
Women & Child Health
168
Capacity Building
43
Pharmacy & Technologies
31
Toolboxes
Mental Health
241
COVID-19
211
TB
197
HIV
191
Planetary Health
138
Pharmacy
92
AMR
84
NTDs
83
Caregiver
76
Rapid Response
73
NCDs
69
Conflict
65
Global Health Education
56
Ebola & Marburg
51
Refugee
47
Disability
44
Specific Hazards
33
Natural Hazards
33
Zika
14
Polio
14
Cholera
13
Health Financing Toolbox
13
Malaria
4
Typhoon
2
Social Ethics
1
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
14–22 April 2015
Recommandations francaises pour la prise enc harge du chikungunya
Médecine e tmaladies infectieuses 45(2015)243–263
The guidelines address timing, number and place of postnatal contacts, and content of postnatal care for all mothers and babies during the six weeks after birth. The primary audience for these guidelines is health professionals who are responsible for providing postnatal care to women and newborns, ...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
The report discusses the epidemiological and social aspects of ageing, health and functional changes experienced with ageing, the impact of physical activity, assessment of the nutritional status of older persons, and nutritional guidelines for healthy ageing.
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Technical Brief
July 2017
Annex 5, WHO Technical Report Series 1010, 2018
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
